Elicio Therapeutics News

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON KAREN J

Nov 25 16:07 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ADAMS JULIAN

Nov 25 07:42 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ashe Carol Gail

Nov 25 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay

Nov 25 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RUFFOLO ROBERT R

Nov 25 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina

Nov 25 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nissenson Allen

Nov 25 07:37 ET

Elicio Therapeutics | 424B3: Prospectus

Nov 22 08:10 ET

Elicio Therapeutics | 8-K: Current report

Nov 21 16:11 ET

Elicio Therapeutics | EFFECT: Others

Nov 21 06:05 ET

Elicio Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 13 16:26 ET

Elicio Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 16:17 ET

Elicio Therapeutics | 8-K: Current report

Nov 13 16:16 ET

Elicio Therapeutics | 8-K: Current report

Nov 7 16:33 ET

Elicio Therapeutics | 8-K: Current report

Nov 7 09:33 ET

Elicio Therapeutics | 8-K: Current report

Oct 17 08:36 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Connelly Robert

Oct 2 16:20 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DeMuth Peter

Oct 2 16:16 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Haqq Christopher

Oct 2 16:16 ET

Elicio Therapeutics | DEF 14A: Definitive information statements

Sep 27 16:45 ET